Fertility and sexual health in adrenal gland disorder
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at fertility and sexual function in people with congenital adrenal hyperplasia (CAH), a condition affecting hormone production. It aims to understand how CAH impacts these areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult between 18 and 55 (if female before menopause) or 18 and 65 (if male)
- You have been diagnosed with congenital adrenal hyperplasia (CAH)
- Your body mass index (BMI) is 40 or lower
- You are not taking any other steroid medications for another condition
- You don't have severe liver or kidney disease, thyroid problems, or cancer
- You are not abusing drugs or alcohol, and you don't have a serious mental health condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who may have too much “androgen” (a hormone) to learn what causes it and how it changes over time. You may be followed even if the exact cause is not yet known, and your results may help doctors better understand these conditions.
This study tests a new drug called OMS1620 to see if it is safe and how the body processes it. It is for healthy adults who may join to help find out if the drug could be used for future treatments.
This trial studies whether a once-daily hydrocortisone tablet works as well as standard steroid treatment for adults with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. It aims to improve how safely and conveniently hormone replacement is taken each day.
This study looks at the long-term experiences of adults with classic congenital adrenal hyperplasia (CAH), a condition affecting hormone production. It aims to understand patient satisfaction and health outcomes over time.
This trial tests a new medicine (NBIP-01435) to see if it helps adults with classic congenital adrenal hyperplasia better manage their condition. The goal is to improve hormone levels and potentially allow for lower steroid doses.
This study tracks adults with congenital adrenal hyperplasia (a condition where the body can't make enough cortisol) who switch to a new form of hydrocortisone called modified-release. It looks at how well the medication works over time and its effects on daily life.
Hear when a new Congenital Adrenal Hyperplasia (CAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.